SMLE Internal Medicine MCQ — High-Yield Topics for GP Doctors
Internal Medicine is usually the heaviest single subject block on SMLE GP papers. This page covers IM-only topic structure, what 2024–2025 sitting recall tends to emphasise, and how to practise—without repeating the general exam overview, MCQ format explanation, full multi-subject syllabus, or week-by-week study plan (those live on the dedicated guides linked below).
~30%
Often cited Medicine share (GP SMLE)
Cardio + endo
Frequently heaviest IM subspecialties
Next best step
Typical stem: diagnosis or management
Weightings summarise common prep-guide and candidate-report ranges (often ~30% for Medicine, sometimes quoted up to ~30–40% depending on grouping). They are not a substitute for the official SCFHS blueprint for your cycle—see scfhs.org.sa and your Mumaris materials.
Where this fits (read this first)
Use these hubs for shared context—then stay on this page for Internal Medicine depth only:
- SMLE exam overview— format, delivery, pass mark, registration context.
- SMLE MCQ bank hub— all subjects, bank organisation, general item style.
- Full syllabus (all subjects)— Medicine alongside Surgery, Paediatrics, and OBGYN.
- 12-week study plan— mixed-subject pacing and timed blocks.
Internal Medicine topic map (SMLE GP)
Third-party SMLE summaries and 2024–2025 GP sitting recall threads tend to align: cardiovascular and endocrine/metabolic items are repeatedly described as the densest IM layers, followed by respiratory, nephrology and fluids, gastroenterology, infectious disease, neurology, and smaller contributions from rheumatology, haematology, and oncology seen through a general medicine lens. The grid below is a revision scaffold—not an official SCFHS topic list.
Cardiology
ACS (STEMI/NSTEMI pathways), acute and chronic heart failure, hypertension emergencies and chronic control, atrial fibrillation (rate versus rhythm, stroke prevention), dyslipidaemia, stable angina versus mimics.
Endocrinology & metabolism
Type 2 diabetes therapies and targets, DKA versus HHS, hypoglycaemia, thyroid storm and myxoedema, adrenal insufficiency, electrolyte patterns driven by endocrine disease.
Respiratory
COPD and asthma exacerbations, pneumonia severity and site-of-care decisions, pulmonary embolism in appropriate pre-test probability, obstructive versus restrictive clues, type 2 respiratory failure.
Nephrology & fluids
AKI causes and staging, hyperkalaemia and ECG linkage, acid–base disorders, diuretic complications, intravenous fluid choices in common scenarios, when dialysis discussion belongs in the stem.
Gastroenterology & hepatology
Upper and lower GI bleeding initial management, acute pancreatitis severity features, cirrhosis complications (ascites, encephalopathy, varices), drug-induced liver injury recognition.
Infectious disease
Sepsis recognition and early management themes, common community infections, HIV-associated presentations at GP depth, travel-related fever frameworks.
Neurology
TIA and stroke timing windows, seizure classification and first-line therapy, meningitis suspicion, acute weakness differentials.
Rheumatology, haematology & oncology (medicine angle)
Inflammatory arthritis and gout flares, anaemia classification, anticoagulant-related bleeding, febrile neutropenia awareness, paraneoplastic clues at recognition level.
High-yield clinical scenarios (IM)
SMLE Medicine stems usually reward sequential, safe GP reasoning: recognise the syndrome, pick the most appropriate next investigation or treatment, and know when to escalate. Patterns commonly echoed for 2024–2025 GP sittings include:
- Chest pain with ECG or biomarker clues—ACS risk stratification and acute management priorities.
- Dyspnoea with cardiac or obstructive lung history—heart failure versus COPD/asthma exacerbation overlap.
- Hyperglycaemia with ketosis or severe hyperosmolarity—DKA versus HHS and initial resuscitation choices.
- New renal dysfunction after contrast, sepsis, or nephrotoxic drugs—AKI cause-and-effect and immediate threats.
- Palpitations or irregular pulse with stroke risk factors—atrial fibrillation rate control, rhythm strategy, and anticoagulation framing.
- Fever, hypotension, or end-organ hypoperfusion—sepsis bundles and source identification thinking.
Internal Medicine–specific study tips (SMLE GP)
Anchor each block to guidelines, not anecdotes. Exam recall frequently tracks international consensus for cardiology, diabetes, and hypertension—know first-line drug classes, hard contraindications, and “red flag” escalations.
Drill “next best step” under time pressure. Many errors come from choosing a correct test or treatment that is logical but not the immediate priority (for example, imaging before stabilisation, or specialist referral before addressing life threats).
Keep electrolytes and ECG paired. Potassium, calcium, and magnesium disturbances often appear with rhythm or weakness stems—practice interpreting urgency from the clinical picture, not memorising isolated numbers.
Cross-link sepsis with organ systems. A pneumonia vignette may still test fluids, oxygenation targets, and antibiotic timing; a UTI in an older patient may pivot to sepsis criteria.
Sample Internal Medicine MCQs
Illustrative samples only — written for this page to show SMLE-style reasoning. They are not taken from the GulfMedExams question bank.
Sample 1
A 68-year-old man with hypertension and diabetes presents with sudden onset palpitations for 6 hours. He feels well perfused. BP 128/78 mmHg, HR 138/min irregularly irregular. ECG shows atrial fibrillation with rapid ventricular response. CHA₂DS₂-VASc score is 4.
What is the most appropriate immediate management alongside assessment for reversible causes?
- A — DC cardioversion without anticoagulation planning
- B — Rate control (e.g. beta-blocker appropriate to his profile) and initiate anticoagulation unless contraindicated, with rhythm strategy decided after stabilisation
- C — Adenosine bolus as first-line
- D — Amiodarone loading only with no rate control
- E — Discharge without follow-up
Answer: B
Haemodynamically stable rapid AF requires rate control and stroke-risk stratification. CHA₂DS₂-VASc 4 strongly supports anticoagulation unless contraindicated. Adenosine is for re-entrant SVT, not AF. Electrical cardioversion without anticoagulation planning can be unsafe depending on duration and risk. Discharge without plan is inappropriate.
Sample 2
A 52-year-old woman with type 2 diabetes presents with polyuria, polydipsia, nausea, and abdominal pain for 2 days. BP 102/64 mmHg, HR 112/min. Glucose 28 mmol/L, ketonuria +++, venous pH 7.22, bicarbonate 12 mmol/L.
What is the most appropriate initial management?
- A — Subcutaneous insulin sliding scale only and discharge
- B — Oral fluids and metformin continuation as sole therapy
- C — Intravenous fluids, intravenous insulin protocol, potassium monitoring and replacement per protocol, and search for precipitant (infection, MI, etc.)
- D — High-dose long-acting insulin glargine only
- E — Sodium bicarbonate infusion routinely for all DKA
Answer: C
This is diabetic ketoacidosis: insulin deficiency with ketosis and acidosis. Initial care is IV fluids, fixed-rate IV insulin with frequent glucose and ketone monitoring, and careful potassium replacement because insulin drives potassium intracellularly. Oral agents alone and outpatient sliding scale are unsafe. Bicarbonate is reserved for selected severe acidosis cases, not routine.
Sample 3
A 74-year-old man with CKD stage 3 presents with weakness and nausea. ECG shows peaked T waves and widened QRS. Serum potassium 6.8 mmol/L, creatinine 320 µmol/L (baseline 150). BP 108/70 mmHg.
What is the most appropriate immediate management?
- A — Oral potassium supplementation
- B — Observe and repeat bloods in one week
- C — Calcium gluconate for membrane stabilisation where indicated, insulin/dextrose and other measures per protocol, nephrology/renal replacement discussion for refractory or severe hyperkalaemia, and treat underlying cause
- D — Loop diuretic challenge as sole therapy in anuria
- E — Discharge on NSAIDs for pain
Answer: C
Severe hyperkalaemia with ECG changes is an emergency: stabilise the myocardium, shift potassium intracellularly, remove potassium (resins, diuretics if appropriate, dialysis when indicated), and stop precipitants. Oral potassium and delayed follow-up are dangerous. NSAIDs can worsen renal function and potassium.
Frequently asked questions — Internal Medicine (SMLE GP)
How much Internal Medicine is on the SMLE GP exam?
Across GP-style SMLE preparation summaries and 2024–2025 candidate discussions, Internal Medicine (often labelled “Medicine” on blueprint-style tables) is frequently quoted as the largest single subject share—commonly around 30% of scored content, with some third-party guides citing a broader ~30–40% band depending on how subspecialty topics are grouped. The authoritative breakdown is whatever SCFHS publishes for your exam cycle; treat percentages here as orientation for study time, not a guarantee for every form.
Which Internal Medicine systems should SMLE GP candidates prioritise?
Prep-community recall from recent GP sittings consistently emphasises cardiology and endocrinology (ACS, heart failure, hypertension, atrial fibrillation, diabetes and diabetic emergencies, thyroid extremes), plus high-volume hospital medicine: respiratory (COPD, asthma, pneumonia, PE), nephrology and electrolytes (AKI, hyperkalaemia), gastroenterology (bleeding, acute abdomen “medicine” decisions), and infectious disease or sepsis framing. Rheumatology, haematology, and neurology appear but usually as a smaller slice of Medicine items.
How is SMLE Internal Medicine different from MRCP-style revision?
SMLE GP items are typically single-best-answer vignettes that reward safe generalist decisions: most likely diagnosis, appropriate first-line investigation, correct next step in management, and major guideline-based choices (without subspecialty minutiae). Breadth and “what would you do on the floor or in clinic Monday morning?” beat rare syndromes.
Do nephrology and electrolytes show up often on SMLE Medicine MCQs?
Yes. Candidate-reported patterns commonly include AKI triggers and staging logic, potassium and acid–base emergencies, diuretic complications, and contrast or drug-related renal injury—often bundled with sepsis, dehydration, or cardiovascular comorbidity.
Is this page for the SMLE Internal Medicine specialty exam?
No. It is written for general practitioners targeting the broad Medicine component of the SMLE GP pathway. If you are sitting a title-specific or specialty SMLE, confirm scope and blueprint in official SCFHS / Mumaris documentation for your category.
Related links
Practise SMLE Internal Medicine MCQs
Open the exam hub, filter by Medicine as labelled in the bank, and run timed mixed blocks so you stay sharp when the exam switches subject domains.
Go to ExamsPrometric® is a registered trademark of Prometric Inc. GulfMedExams is an independent platform and is not affiliated with or endorsed by Prometric or any licensing authority. Content on this page is for educational preparation only and does not replace official SCFHS guidance.